C-Biomex logo — company profile

C-Biomex

Founded 2017 Series B Total: $6.50B Biotechnology, Pharmaceutical

General Information

Company Name C-Biomex
Founded Year 2017
Industries Biotechnology, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with C-Biomex. To contact C-Biomex, visit cbiomex.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About C-Biomex

C-Biomex is a biotechnology and pharmaceutical startup that was founded in 2017. The company recently raised a significant investment of KRW6.50B in a Series B - C funding round on 22 June 2022. The investment was led by a group of prominent investors including Mirae Asset Venture Investment, Stassets Investment, Enlight Ventures, Innopolis Partners, SHINPOONG.CO, and E&Venture Partners. This latest round of funding reflects the confidence that investors have in the potential of C-Biomex and its innovative approach in the biotechnology and pharmaceutical industries.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B C KRW6.50B 6
Mirae Asset Venture Investment, Stassets Investment +4
22 Jun 2022

FAQ About C-Biomex

C-Biomex was founded in 2017.
C-Biomex operates in Biotechnology and Pharmaceutical.
C-Biomex has completed 1 funding round, raising a total of $6.50B. The latest funding stage is Series B.

We're actively collecting intelligence on C-Biomex.

Source: BounceWatch company record for C-Biomex, https://bouncewatch.com/company/c-biomex, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes